GV MED
The computed 12-month bankruptcy probability of GV MED is 2.4% (moderate). The 2025 annual accounts show equity of €134k and a net result of €64k. The company has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €134k |
| Net result | €64k |
| Active | 2 yrs |
| Locations | 1 |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Fiscal year | 2025 |
|---|---|
| Revenue | - |
| EBITDA | €98k |
| Net profit | €64k |
| Cash flow | €70k |
| Staff costs | - |
| Income taxes | €28k |
| Dividends | - |
| Total assets | €146k |
| Equity | €134k |
| Debt | €12k |
| of which ≤ 1y | €12k |
| of which > 1y | - |
| Working capital | €116k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 10.71 |
| Quick ratio | 10.71 |
| Working capital ratio | 79.3% |
| Solvency | 91.8% |
| Debt / equity | 0.09 |
| Long-term debt ratio | - |
| Interest coverage | 1834.43 |
| Gross margin | - |
| Net margin | - |
| ROA | 44.0% |
| ROE | 47.9% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €146k |
| Fixed assets | 21/28 | €18k |
| Tangible fixed assets | 22/27 | €18k |
| Current assets | 29/58 | €127k |
| Amounts receivable within one year | 40/41 | €13k |
| Investments | 50/53 | €60k |
| Cash & bank | 54/58 | €22k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €146k |
| Equity | 10/15 | €134k |
| Contributions / capital | 10/11 | €1 |
| Reserves | 13 | €134k |
| Amounts payable | 17/49 | €12k |
| Amounts payable within one year | 42/48 | €12k |
| Trade debts payable within one year | 44 | €702 |
| Income statement | ||
| Gross operating margin | 9900 | €98k |
| Operating result | 9901 | €92k |
| Financial income | 75 | €23 |
| Financial charges | 65 | €54 |
| Result before taxes | 9903 | €92k |
| Income taxes | 67/77 | €28k |
| Net result for the period | 9904 | €64k |
| Result to be appropriated | 9905 | €64k |
| NACE primary | - |
| Legal form | Private limited company(610) |
| Incorporation | 15-09-2023 |
| Status | Active |
| Postal code | 1380 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25087C0461/00F000 | Wallonia | 787 m² | 1 · 138 m² | 8.5 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
17-05-2024 Publication in the Belgian Official Gazette, Miscellaneous
Technical details
{
"stage": null,
"notary": {
"name": "Jean FONTEYN",
"firm_city": null,
"firm_name": null,
"office_city": "Seneffe",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-05-17",
"filing_date": "2024-05-15",
"act_kind_objet": "DIVERS"
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2024-05-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "material_correction",
"report_waiver": null,
"restructuring": null,
"subject_company": {
"kbo": "0805.878.275",
"name_full": "GV MED",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Jean FONTEYN",
"org_rep_person_name": null
},
"summary_narrative": "This act corrects a material error in the original publication of the company\u0027s incorporation act from September 19, 2023. The correction specifies that the first fiscal exercise ends on September 30, 2024, instead of December 30, 2024.",
"co_filed_documents": [],
"detected_real_type": "material_correction",
"referenced_correction": {
"prior_pub_date": "2023-09-19",
"what_corrected": "The end date of the first fiscal exercise.",
"prior_pub_number": "23393044"
},
"should_reroute_to_category": null
}26-04-2024 Registered office moved from Grez-Doiceau to Plancerioit
- Champ de Maubroux 21, 1390 Grez-Doiceau → Averue Général Cambronne 17, 1380 Plancerioit
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Averue G\u00E9n\u00E9ral Cambronne 17, 1380 Plancerioit",
"city": "Plancerioit",
"region": "waals_gewest",
"street": "Averue G\u00E9n\u00E9ral Cambronne",
"country": "BE",
"postcode": "1380",
"box_number": null,
"street_number": "17",
"locality_suffix": null
},
"old_address": {
"raw": "Champ de Maubroux 21, 1390 Grez-Doiceau",
"city": "Grez-Doiceau",
"region": "waals_gewest",
"street": "Champ de Maubroux",
"country": "BE",
"postcode": "1390",
"box_number": null,
"street_number": "21",
"locality_suffix": null
},
"effective_date": "2024-03-14",
"evidence_quote": "Conform\u00E9ment \u00E0 l\u0027article 2 des statuts, l\u0027administrateur d\u00E9cide de transf\u00E9rer \u00E0 dater du jeudi 14/03/2024 le si\u00E8ge sacial de la Soci\u00E9t\u00E9 \u00E0 l\u0027adresse suivante: Averue G\u00E9n\u00E9ral Cambronne 17, 1380 Plancerioit.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": 2,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2024-03-29",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enige_bestuurder",
"date": "2024-03-29",
"unanimous": null
},
"subject_company": {
"kbo": "0805.878.275",
"name_full": "GV MED",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Laurence Vandeplas",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | GV MED |